MRD Testing in Breast Cancer: ASBrS 2025 Impact ASBrS 3 Mins Read At ASBrS 2025, experts showcased how MRD testing in breast cancer is revolutionizing patient care. Using Natera’s Signatera, clinicians detect circulating tumor…
Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD General 3 Mins Read Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility…
